Consensus Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Market Closed - Nasdaq Other stock markets 04:00:02 2024-04-23 pm EDT			5-day change	1st Jan Change
10.84 ^USD	-2.34%		-5.98%	-14.98%

Mar. 25	Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	MT
Feb. 27	Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024

Evolution of the average Target Price on Treace Medical Concepts, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c66e14658db079.rdwm74rtuHTSb4zaZuEOdpOZbaZSwLMw4bfG0A1VaBk.2u1il7uHiB6hF92eHtNqM_vcN-dqt9dFmNC34lkHWnTZqlW3-IDuOLY81Q~2046b8e124780503e63c583cd1162c3f

Analyst Recommendations on Treace Medical Concepts, Inc.

Truist Securities Adjusts Price Target on Treace Medical Concepts to $16 From $12, Keeps Buy Rating	Dec. 22	MT
UBS Adjusts Price Target on Treace Medical Concepts to $17 From $24, Maintains Buy Rating	Nov. 13	MT
Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $14 From $30, Maintains Overweight Rating	Nov. 13	MT
Truist Adjusts Price Target on Treace Medical Concepts to $12 From $17, Maintains Buy Rating	Nov. 10	MT
UBS Initiates Treace Medical Concepts With Buy Rating, Price Target is $24	23-09-29	MT
BTIG Adjusts Treace Medical Concepts' Price Target to $27.50 From $32, Keeps Buy Rating	23-08-28	MT
Stephens Adjusts Price Target on Treace Medical Concepts to $25 From $27, Keeps Equalweight Rating	23-08-10	MT
Truist Securities Adjusts Price Target on Treace Medical Concepts to $30 From $33, Maintains Buy Rating	23-08-09	MT
Truist Starts Treace Medical Concepts at Buy With $33	23-05-01	MT
BTIG Adjusts Price Target on Treace Medical Concepts to $32 From $29, Maintains Buy Rating	23-04-17	MT
Stephens Starts Treace Medical Concepts at Equalweight With $26 Price Target	23-04-11	MT
Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $30 From $28, Maintains Overweight Rating	23-03-08	MT
Morgan Stanley Adjusts Treace Medical Concepts' Price Target to $28 from $23, Maintains Overweight Rating	22-10-11	MT
BTIG Raises Price Target on Treace Medical Concepts to $28 From $23, Keeps Buy Rating	22-09-21	MT
Stifel Nicolaus Adjusts Treace Medical Concepts Price Target to $27 From $24, Maintains Buy Rating	22-09-21	MT
Stifel Nicolaus Adjusts Price Target for Treace Medical Concepts to $24 From $21, Maintains Buy Rating	22-08-10	MT
Stifel Lowers Treace Medical Concepts' Price Target to $21 From $32, Maintains Buy Rating	22-07-18	MT
Morgan Stanley Lowers Treace Medical Concepts' Price Target to $22 From $26, Maintains Overweight Rating	22-07-15	MT
BTIG Initiates Treace Medical Concepts at Buy, Sets Price Target at $22	22-05-12	MT
Stifel Adjusts Treace Medical Concepts' Price Target to $32 From $37, Keeps Buy Rating	22-03-04	MT
Morgan Stanley Adjusts Treace Medical Concepts' Price Target to $28 From $30, Maintains Overweight Rating	22-03-04	MT
Morgan Stanley Upgrades Treace Medical Concepts to Overweight From Equalweight; Price Target is $30	22-01-07	MT
TREACE MEDICAL CONCEPTS : Morgan Stanley Adjusts Treace Medical Concepts' Price Target to $32 From $30, Keeps Equal-Weight Rating	21-05-26	MT
TREACE MEDICAL CONCEPTS : SVB Leerink Starts Treace Medical Concepts at Outperform with $38 Price Target	21-05-24	MT
TREACE MEDICAL CONCEPTS : Morgan Stanley Starts Treace Medical Concepts at Equal-Weight With $30 Price Target	21-05-18	MT